Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3r6p | A8S | Abscisic acid receptor PYL10 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3r6p | A8S | Abscisic acid receptor PYL10 | / | 1.000 | |
| 3oqu | A8S | Abscisic acid receptor PYL9 | / | 0.534 | |
| 4dsc | A8S | Abscisic acid receptor PYL3 | / | 0.534 | |
| 3njo | P2M | Abscisic acid receptor PYR1 | / | 0.532 | |
| 3nef | PYV | Abscisic acid receptor PYL1 | / | 0.517 | |
| 3neg | PYV | Abscisic acid receptor PYL1 | / | 0.517 | |
| 3w9r | A8S | Abscisic acid receptor PYL9 | / | 0.507 | |
| 4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.498 | |
| 3ujl | A8S | Abscisic acid receptor PYL2 | / | 0.492 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.491 | |
| 3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.489 | |
| 3ns2 | PYV | Abscisic acid receptor PYL2 | / | 0.487 | |
| 4oic | A8S | Bet v I allergen-like | / | 0.486 | |
| 2qo6 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.482 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.481 | |
| 4jda | A9S | Abscisic acid receptor PYL3 | / | 0.480 | |
| 4lg5 | A1O | Abscisic acid receptor PYL2 | / | 0.480 | |
| 3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.478 | |
| 4la7 | A1O | Abscisic acid receptor PYL2 | / | 0.478 | |
| 4ds8 | A8S | Abscisic acid receptor PYL3 | / | 0.473 | |
| 2qo4 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.472 | |
| 3kdi | A8S | Abscisic acid receptor PYL2 | / | 0.472 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.471 | |
| 3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.471 | |
| 4dsb | A8S | Abscisic acid receptor PYL3 | / | 0.467 | |
| 1l2j | ETC | Estrogen receptor beta | / | 0.466 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.466 | |
| 3eej | 53R | Uncharacterized protein | / | 0.464 | |
| 4lga | A2O | Abscisic acid receptor PYL2 | / | 0.463 | |
| 1rk3 | VDX | Vitamin D3 receptor | / | 0.462 | |
| 1ysx | 4EB | Serum albumin | / | 0.462 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.462 | |
| 3k3k | A8S | Abscisic acid receptor PYR1 | / | 0.461 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.461 | |
| 5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.461 | |
| 2qd3 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.460 | |
| 1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.459 | |
| 3nmn | PYV | Abscisic acid receptor PYL1 | / | 0.458 | |
| 3zvu | A8S | Abscisic acid receptor PYR1 | / | 0.458 | |
| 1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
| 2zb4 | 5OP | Prostaglandin reductase 2 | 1.3.1.48 | 0.457 | |
| 4ajw | VWN | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 2.7.1.153 | 0.457 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
| 1txi | TX5 | Vitamin D3 receptor | / | 0.456 | |
| 3qly | 55V | Uncharacterized protein | / | 0.456 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.456 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
| 4g1z | 0VP | Vitamin D3 receptor A | / | 0.456 | |
| 4ite | TEY | Vitamin D3 receptor | / | 0.456 | |
| 1dkf | BMS | Retinoic acid receptor alpha | / | 0.455 | |
| 3kb3 | A8S | Abscisic acid receptor PYL2 | / | 0.455 | |
| 4fhi | 0S4 | Vitamin D3 receptor A | / | 0.455 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.454 | |
| 1rkg | VD1 | Vitamin D3 receptor | / | 0.454 | |
| 1rkh | VD2 | Vitamin D3 receptor | / | 0.454 | |
| 2hb8 | MVD | Vitamin D3 receptor | / | 0.454 | |
| 2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.454 | |
| 3lu8 | IQX | Serum albumin | / | 0.454 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.454 | |
| 1db1 | VDX | Vitamin D3 receptor | / | 0.453 | |
| 2qbl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
| 4bbh | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.453 | |
| 1klk | PMD | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
| 3kdj | A8S | Abscisic acid receptor PYL1 | / | 0.452 | |
| 3qn1 | A8S | Abscisic acid receptor PYR1 | / | 0.452 | |
| 4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
| 3vrw | YS5 | Vitamin D3 receptor | / | 0.451 | |
| 4ea1 | 3RX | Dehydrosqualene synthase | / | 0.451 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.451 | |
| 3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.450 | |
| 3ls8 | AJZ | Phosphatidylinositol 3-kinase catalytic subunit type 3 | 2.7.1.137 | 0.450 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.450 | |
| 1s3v | TQD | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 2has | C3O | Vitamin D3 receptor | / | 0.449 | |
| 3aba | FLI | Cytochrome P450 | / | 0.449 | |
| 3vt6 | 5YI | Vitamin D3 receptor | / | 0.449 | |
| 4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.449 | |
| 2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.448 | |
| 3gkj | HC3 | Niemann-Pick C1 protein | / | 0.448 | |
| 3u8h | BHP | Phospholipase A2, membrane associated | / | 0.448 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4l8u | 9AZ | Serum albumin | / | 0.448 | |
| 4mxe | ACO | N-acetyltransferase ESCO1 | 2.3.1 | 0.448 | |
| 1cjc | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.447 | |
| 1d2s | DHT | Sex hormone-binding globulin | / | 0.446 | |
| 2azy | CHD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.446 | |
| 2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.446 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.446 | |
| 3c3d | FO1 | 2-phospho-L-lactate transferase | / | 0.446 | |
| 1ie8 | KH1 | Vitamin D3 receptor | / | 0.445 | |
| 1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 1s19 | MC9 | Vitamin D3 receptor | / | 0.445 | |
| 2hb7 | O1C | Vitamin D3 receptor | / | 0.445 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.445 | |
| 3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.445 | |
| 3w5r | LOA | Vitamin D3 receptor | / | 0.445 | |
| 4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.445 | |
| 5dq8 | FLF | Transcriptional enhancer factor TEF-4 | / | 0.445 | |
| 1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.444 | |
| 1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 2hrc | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.444 | |
| 2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.444 | |
| 2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.444 | |
| 3w0h | W12 | Vitamin D3 receptor | / | 0.444 | |
| 4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
| 4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 4h97 | 53S | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1t0l | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.443 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.443 | |
| 3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.443 | |
| 3vwe | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.443 | |
| 4euf | NAD | Trans-2-enoyl-CoA reductase [NADH] | / | 0.443 | |
| 4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.443 | |
| 4itf | TFY | Vitamin D3 receptor | / | 0.443 | |
| 1ie9 | VDX | Vitamin D3 receptor | / | 0.442 | |
| 2vf0 | F89 | Thymidylate synthase | / | 0.442 | |
| 2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.442 | |
| 3cr7 | PPS | Adenylyl-sulfate kinase | 2.7.1.25 | 0.442 | |
| 3vtc | TK3 | Vitamin D3 receptor | / | 0.442 | |
| 3w5p | 4OA | Vitamin D3 receptor | / | 0.442 | |
| 4ruo | BIV | Vitamin D3 receptor A | / | 0.442 | |
| 1tdr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 3w0a | DS5 | Vitamin D3 receptor | / | 0.441 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.441 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.441 | |
| 4q0a | 4OA | Vitamin D3 receptor A | / | 0.441 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.441 | |
| 2ham | C33 | Vitamin D3 receptor | / | 0.440 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.440 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 2ww4 | ADP | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.440 | |
| 4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.440 | |
| 4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.440 | |
| 4l4b | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
| 4l9k | EHF | Serum albumin | / | 0.440 |